Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Warr

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Journal of the National Cancer Institute|October 4, 1989
Combination chemotherapy with doxorubicin, dacarbazine, and ifosfamide in advanced adult soft tissue sarcoma. Canadian Sarcoma Group--National Cancer Institute of Canada Clinical Trials GroupV Bramwell, I Quirt, D Warr, et al.
The Canadian Journal of Oncology|February 1, 1996
The role of palliative thoracic radiotherapy in non-small cell lung cancerM D Brundage, A Bezjak, P Dixon, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 18, 1998
Consensus proposal for 5HT3 antagonists in the prevention of acute emesis related to highly emetogenic chemotherapy. Dose, schedule, and route of administrationD R Gandara, F Roila, D Warr, et al.
Archives of Internal Medicine|March 22, 1993
Ectopic corticotropin syndrome and small-cell carcinoma of the lung. Clinical features, outcome, and complicationsL Delisle, M J Boyer, D Warr, et al.
Psycho-Oncology|January 13, 1999
A randomized controlled trial of the effects of group psychological therapy on survival in women with metastatic breast cancerA J Cunningham, C V Edmonds, G P Jenkins, et al.
International Journal of Radiation Oncology, Biology, Physics|December 1, 1993
Outcome and prognostic factors in soft tissue sarcoma in the adultJ LeVay, B O'Sullivan, C Catton, et al.
Breast Cancer Research and Treatment|September 8, 2012
A randomized double-blind placebo-controlled cross-over trial of the impact on quality of life of continuing dexamethasone beyond 24 h following adjuvant chemotherapy for breast cancerJ Vardy, G Pond, A Dodd, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1994
Effect of schedule and maintenance on the antiemetic efficacy of ondansetron combined with dexamethasone in acute and delayed nausea and emesis in patients receiving moderately emetogenic chemotherapy: a phase III trial by the National Cancer Institute of Canada Clinical Trials GroupL Kaizer, D Warr, P Hoskins, et al.
Drugs|January 1, 1993
The Canadian experience with intensive fluorouracil, epirubicin and cyclophosphamide in patients with early stage breast cancerM N Levine, V Bramwell, K Pritchard, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
A randomised, double-blind comparison of granisetron with high-dose metoclopramide, dexamethasone and diphenhydramine for cisplatin-induced emesis. An NCI Canada Clinical Trials Group Phase III TrialD Warr, A Wilan, P Venner, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Journal of the National Cancer Institute|October 4, 1989
Combination chemotherapy with doxorubicin, dacarbazine, and ifosfamide in advanced adult soft tissue sarcoma. Canadian Sarcoma Group--National Cancer Institute of Canada Clinical Trials GroupV Bramwell, I Quirt, D Warr, et al.
The Canadian Journal of Oncology|February 1, 1996
The role of palliative thoracic radiotherapy in non-small cell lung cancerM D Brundage, A Bezjak, P Dixon, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 18, 1998
Consensus proposal for 5HT3 antagonists in the prevention of acute emesis related to highly emetogenic chemotherapy. Dose, schedule, and route of administrationD R Gandara, F Roila, D Warr, et al.
Archives of Internal Medicine|March 22, 1993
Ectopic corticotropin syndrome and small-cell carcinoma of the lung. Clinical features, outcome, and complicationsL Delisle, M J Boyer, D Warr, et al.
Psycho-Oncology|January 13, 1999
A randomized controlled trial of the effects of group psychological therapy on survival in women with metastatic breast cancerA J Cunningham, C V Edmonds, G P Jenkins, et al.
International Journal of Radiation Oncology, Biology, Physics|December 1, 1993
Outcome and prognostic factors in soft tissue sarcoma in the adultJ LeVay, B O'Sullivan, C Catton, et al.
Breast Cancer Research and Treatment|September 8, 2012
A randomized double-blind placebo-controlled cross-over trial of the impact on quality of life of continuing dexamethasone beyond 24 h following adjuvant chemotherapy for breast cancerJ Vardy, G Pond, A Dodd, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1994
Effect of schedule and maintenance on the antiemetic efficacy of ondansetron combined with dexamethasone in acute and delayed nausea and emesis in patients receiving moderately emetogenic chemotherapy: a phase III trial by the National Cancer Institute of Canada Clinical Trials GroupL Kaizer, D Warr, P Hoskins, et al.
Drugs|January 1, 1993
The Canadian experience with intensive fluorouracil, epirubicin and cyclophosphamide in patients with early stage breast cancerM N Levine, V Bramwell, K Pritchard, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
A randomised, double-blind comparison of granisetron with high-dose metoclopramide, dexamethasone and diphenhydramine for cisplatin-induced emesis. An NCI Canada Clinical Trials Group Phase III TrialD Warr, A Wilan, P Venner, et al.
Pageof 5